Pfizer Raises 2021 Sales Forecast For COVID-19 Vaccines To $26 Billion
Pfizer has sharply increased its projections for 2021 revenues and profits, citing much higher COVID-19 vaccine sales, as it targets the inoculations as a “durable” revenue stream.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
Pfizer Raises 2021 Sales Forecast For COVID-19 Vaccines To $26 Billion
Pfizer has sharply increased its projections for 2021 revenues and profits, citing much higher COVID-19 vaccine sales, as it targets the inoculations as a “durable” revenue stream.